🔎 Trials Near Me

Inicio › Cáncer de pulmón › Maine

Ensayos clínicos de Cáncer de pulmón en Maine

12 estudios sobre Cáncer de pulmón buscan participantes en Maine.

Ciudades en Maine

Texto oficial del estudio (inglés)

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Maine Medical Center, Portland
  • MaineHealth Cancer Care and Blood Disorders Scarborough, Scarborough
  • MaineHealth Cancer Care and IV Therapy - South Portland, South Portland
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Harold Alfond Center for Cancer Care, Augusta
  • MaineHealth Maine Medical Center- Scarborough, Scarborough
  • MaineHealth Cancer Care and IV Therapy - South Portland, South Portland
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Harold Alfond Center for Cancer Care, Augusta
  • MaineHealth Waldo Hospital, Belfast
  • Lafayette Family Cancer Center-EMMC, Brewer
  • y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04267848

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • Lafayette Family Cancer Center-EMMC, Brewer
ReclutandoFase 3
Edades de 70 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06096844

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Harold Alfond Center for Cancer Care, Augusta
  • MaineHealth Waldo Hospital, Belfast
  • Lafayette Family Cancer Center-EMMC, Brewer
  • y 9 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Lafayette Family Cancer Center-EMMC, Brewer
ReclutandoFase 2
18 Minutes · Todos los sexos · Actualizado el 9 oct 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Harold Alfond Center for Cancer Care, Augusta
  • MaineHealth Waldo Hospital, Belfast
  • Lafayette Family Cancer Center-EMMC, Brewer
  • y 6 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06616584

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • MaineHealth Maine Medical Center - Portland, Portland
  • MaineHealth Cancer Care Center of York County, Sanford
  • MaineHealth Maine Medical Center- Scarborough, Scarborough
  • y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Lafayette Family Cancer Center-EMMC, Brewer
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT05642572

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Scarborough
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.